Rohto Hopes For A Repeated Strong Record In Upcoming Allergy Season
This article was originally published in PharmAsia News
Executive Summary
Stocks of Rohto Pharmaceuticals Co. are down to ¥1,225 due to the lowering of the Dow Index and the appreciating yen. However, with the estimated higher pollen counts predicted for the spring of 2008, Rohto has high hopes for a strong record during the upcoming allergy season